Former Mahindra CEO Pawan Goenka joins Bosch and Sun Pharmaceutical as an independent director

Former Mahindra CEO Pawan Goenka joins Bosch and Sun Pharmaceutical as an independent director

FPJ Web DeskUpdated: Friday, May 21, 2021, 12:00 AM IST
article-image
Former Mahindra MD Pawan Goenka joins Bosch and Sun Pharmaceutical as an independent director | twitter

Pawan Goenka, former managing director of Mahindra & Mahindra, retired on April 1 from the company. Now, he has joined the board of technology and engineering company Bosch as an independent director and board of drug firm Sun Pharmaceutical as an additional independent director.

In both companies, he has been appointed to the board from May 21, 2021. The board of directors at Bosch approved the appointment of Pawan Kumar Goenka as independent director for a period of five years with effect from May 21, 2021.

Goenka served on the boards of several Mahindra Group Companies both domestic and International.

Goenka was appointed Executive Director and President (AFS) on the Board of Mahindra & Mahindra in September 2013. He retired from Mahindra as Managing Director and CEO on April 1, 2021.

He joined Mahindra & Mahindra Ltd as General Manager (R&D). During his R&D tenure he led the development of the Scorpio SUV. He was appointed COO (Automotive Sector) in April 2003, President (Automotive Sector) in September 2005, President (Automotive & Farm Equipment Sectors) in April 2010.

Prior to joining M&M, he worked at General Motors R&D Centre in the USA from 1979 to 1993.

RECENT STORIES

What The Union Budget Means For India’s Youth
What The Union Budget Means For India’s Youth
93% Of Travellers Link In-Flight Comfort To Post-Landing Well-being, 60% Flyers Willing To Pay Extra...
93% Of Travellers Link In-Flight Comfort To Post-Landing Well-being, 60% Flyers Willing To Pay Extra...
PFC–REC Merger Likely To Boost Renewable Financing, Strengthen Grid Funding And Expand...
PFC–REC Merger Likely To Boost Renewable Financing, Strengthen Grid Funding And Expand...
Godrej Consumer Q3 Profit Surges 62% QoQ To ₹529 Crore, Revenue Grows 5% YoY To ₹3,694 Crore
Godrej Consumer Q3 Profit Surges 62% QoQ To ₹529 Crore, Revenue Grows 5% YoY To ₹3,694 Crore
Will Raising STT Actually Stop Speculation?
Will Raising STT Actually Stop Speculation?